Kidney TransplantationTransplantation, HomologousGraft SurvivalGraft RejectionImmunosuppressive AgentsHematopoietic Stem Cell TransplantationBone Marrow TransplantationTissue DonorsTransplantsHistocompatibility TestingTransplantation ConditioningGraft vs Host DiseaseTransplantation, AutologousTime FactorsHematologic NeoplasmsRetrospective StudiesPostoperative ComplicationsTreatment OutcomeHeart TransplantationTransplantationLung TransplantationLiver TransplantationAcute DiseaseRecurrenceTissue and Organ ProcurementCyclosporineTacrolimusLiving DonorsCombined Modality TherapyWaiting ListsPost and Core TechniqueImmunosuppressionFetal Tissue TransplantationCytomegalovirus InfectionsMycophenolic AcidCadaverTransplantation ImmunologyImmunocompromised HostKidney Failure, ChronicLiver FailureHeart-Lung TransplantationBrain Tissue TransplantationFollow-Up StudiesRisk FactorsBronchiolitis ObliteransTransplantation, HeterotopicHistocompatibilityTransplantation ToleranceOpportunistic InfectionsCytomegalovirusBK VirusSurvival RateSurvival AnalysisBiopsyHLA AntigensGanciclovirProspective StudiesAntilymphocyte SerumIsoantibodiesKidneyPolyomavirus InfectionsLymphoproliferative DisordersEnd Stage Liver DiseaseTransplantation, IsogeneicCreatinineKidney DiseasesIncidenceLiver DiseasesIslets of Langerhans TransplantationPostoperative PeriodMycosesAntiviral AgentsPrimary Graft DysfunctionFatal OutcomeWhole-Body IrradiationSirolimusStem Cell TransplantationPrognosisCohort StudiesCalcineurinPatient SelectionDrug Therapy, CombinationDirected Tissue DonationTransplantation ChimeraInfectionRenal DialysisCord Blood Stem Cell TransplantationKaplan-Meier EstimateLeukemiaRegistriesRisk AssessmentBrain DeathProportional Hazards ModelsMultivariate AnalysisFacial TransplantationReoperationCyclosporinsAspergillosisCorneal TransplantationGlomerular Filtration Rate